权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

RETROVIRUS REGULATION IN VITRO AND DURING DEVELOPMENT

体外和开发过程中的逆转录病毒监管

基本信息

批准号：
6179754
负责人：
KATHLEEN F CONKLIN
金额：
$ 22.37万
依托单位：
UNIVERSITY OF MINNESOTA
依托单位国家：
美国
项目类别：
财政年份：
1989
资助国家：
美国
起止时间：
1989-07-01 至 2002-03-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/6179754
关键词：
B cell lymphoma B lymphocyte Retroviridae Rous sarcoma virus chickens genetic regulation molecular cloning nucleic acid repetitive sequence provirus recombinant virus tissue /cell culture viral carcinogenesis virus infection mechanism

项目摘要

A well documented feature of retroviruses is that most virus isolates, although able to replicate in a wide variety of tissues in infected animals, induce tumors in only one or a small number of cell types. For non-acute transforming avian and murine retroviruses, which by definition do not contain viral-associated oncogenes, the specificity of tumor induction as well as the frequency with which a virus causes disease, segregate primarily with the long terminal repeat (LTR) that contains the viral enhancer and promoter. Experiments are proposed in this application to use avian non-acute transforming viruses to investigate properties of different viral LTRs that define (a) the frequency and (b) the specificity of tumor induction and (c) the mechanism(s) employed to disrupt expression of cellular genes at sites of provirus integration in tumors. These areas are investigated by defining the transcriptional properties of wild type, mutant, and recombinant LTRs from highly and weakly oncogenic viruses and by in vivo oncogenicity testing of replication competent viruses that include these LTRs. Experiments are also included to characterize a novel common integration site (bravo) that has been defined in avian retrovirus induced B cell lymphomas and to determine the effects of provirus integration at this locus. Studies in this application will contribute to our understanding of the identity and regulation of viral elements involved in tumor induction and of the role that cellular transcription factors and cellular oncogenes play in this process as well. In addition, the proposed studies on the bravo locus are likely to yield important information in light of the fact that many of the previously characterized common provirus integration sites in tumors identify genes that contribute to both normal cell growth, differentiation or development and, in their abnormal form, to cellular transformation.

逆转录病毒的一个有据可查的特征是大多数病毒分离株，尽管能够在感染的多种组织中复制，在动物中，仅在一种或少数细胞类型中诱导肿瘤。为非急性转化性禽和鼠逆转录病毒，根据定义，不含病毒相关癌基因，肿瘤的特异性诱导以及病毒引起疾病的频率，分离主要与长末端重复序列（LTR），其中包含病毒增强子和启动子。在此应用中提出了实验利用禽非急性转化病毒研究定义（a）频率和（B）特异性的不同病毒LTR 和（c）用于破坏表达的机制在肿瘤中前病毒整合位点的细胞基因。这些领域通过定义野生型的转录特性来研究，来自高度和弱致癌病毒的突变体和重组LTR，通过复制能力病毒的体内致瘤性测试，包括这些土地登记册。实验也包括表征一个新的在禽逆转录病毒中定义的共同整合位点（bravo）诱导的B细胞淋巴瘤，并确定前病毒的作用整合在这个位置上。这项应用研究将有助于我们对病毒成分的身份和调控的理解在肿瘤诱导中的作用以及细胞转录因子和细胞癌基因也参与了这一过程。此外，拟议的对bravo基因座的研究可能会产生重要的信息，鉴于许多先前表征的常见前病毒肿瘤中的整合位点识别出有助于正常细胞生长、分化或发育，以及在它们的异常形式中，到细胞转化。